History of Oncology
Hippocrates (460.370 B.C.) used the terms carcinoma to describe non-ulcer forming and ulcer-forming tumors. In Greek, these words refer to a crab, because the finger-like spreading projections from a tumor called to mind the shape of a crab
The
oldest specimen of a human tumor was found in the remains of skull of a female who
lived during the Bronze Age (1900-1600 BC)
The Roman physician Galen (130-200 A.D.) used the word oncos (Greek for swelling) to describe tumours
In the Roman-Byzantine Empire, physicians of Constantinople school explained that the cause of cancer was an excess of black bile
In 1775 the English surgeon Percivall Pott (London, 1714-1788) described an occupational cancer of the scrotum in chimney sweeps, caused by soot collecting under the scrotum
In the 19th century, the German scientist Rudolf Virchow (1821-1902), often called the "founder of cellular pathology", provided the scientific basis for the modern cytological research and pathologic study of cancer
Wilhelm Conrad Röntgen (Remscheid, Germany, 1845 – 1923): "On a new kind of rays", Science 1896 Feb 14;3(59):227-31
Pierre Curie (Paris, 1859–1906) and Marie Sklodowska Curie (Warsaw, 1867–1934) discovered the radioactive element radium in 1898
1910 - Discovery of a viral cause of avian cancer by
Francis Peyton Rous (Baltimora, October 5, 1879 - New York, February 16,
1970). Rous
P. : "A
transmissible avian neoplasm (Sarcoma of the common
fowl)", J Exp Med. 1910 Sep 1;12(5).696-705
1914 - Proposal by Theodor Boveri (Bamberg, 1862 - Wurzburg, 1915) that cancer can be triggered by chromosomal mutations
Yale University, USA, 1943: Use of nitrogen mustard in lymphomas (Goodman
LS et al., Journal of the American Medical Association)
Sidney Farber (1903–1973)
showed for the first time in 1948 that folic acid antagonists could induce
temporary remission in childhood leukemia (Farber
S et al.: “Temporary remissions in acute leukemia in children produced
by folic acid antagonist, 4-amino-pteroyl-glutamic acid (aminopterin)”, N Engl J Med
1948;238:787-793)
1976 - Gianni Bonadonna (Milan, Italy):
"Our data indicate that
patients with potentially curable breast cancer and with positive axillary
lymph nodes at the time of mastectomy show a statistically significant
reduction in recurrence rate during the first 27 months after radical
mastectomy when treated with cyclic prolonged combination chemotherapy. At
present, the advantage of CMF appears statistically evident in all
subgroups of patients" (Bonadonna
G et al.: "Combination
chemotherapy as an adjuvant treatment in operable breast cancer
", N Engl J Med. 1976 Feb 19;294(8):405-10)